This can include the base of the tongue and tonsils. Cancer often takes years, even decades, to develop after a person gets HPV. Genital warts and cancers result from different types of HPV.
There is no way to know who will develop cancer or other health problems from HPV. They may also be more likely to develop health problems from HPV. Get vaccinated. The HPV vaccine is safe and effective. It can protect against diseases including cancers caused by HPV when given in the recommended age groups. Get screened for cervical cancer. Routine screening for women aged 21 to 65 years old can prevent cervical cancer.
Vaccination is not recommended for everyone older than age 26 years. However, some adults age 27 through 45 years who are not already vaccinated may decide to get the HPV vaccine after speaking with their healthcare provider about their risk for new HPV infections and the possible benefits of vaccination.
HPV vaccination in this age range provides less benefit. Most sexually active adults have already been exposed to HPV, although not necessarily all of the HPV types targeted by vaccination. At any age, having a new sex partner is a risk factor for getting a new HPV infection. People who are already in a long-term, mutually monogamous relationship are not likely to get a new HPV infection. Late Effects of Childhood Cancer Treatment. Pediatric Supportive Care.
Rare Cancers of Childhood Treatment. Childhood Cancer Genomics. Study Findings. Metastatic Cancer Research. Intramural Research. Extramural Research. Cancer Research Workforce.
Partners in Cancer Research. What Are Cancer Research Studies. Research Studies. Get Involved. Cancer Biology Research. Cancer Genomics Research.
Research on Causes of Cancer. Cancer Prevention Research. Cancer Treatment Research. Cancer Health Disparities. Childhood Cancers Research. Global Cancer Research. Cancer Research Infrastructure. Clinical Trials. Frederick National Laboratory for Cancer Research. Bioinformatics, Big Data, and Cancer. Annual Report to the Nation. Research Advances by Cancer Type.
Stories of Discovery. Milestones in Cancer Research and Discovery. Biomedical Citizen Science. Director's Message. Budget Proposal. Stories of Cancer Research. Driving Discovery. Highlighted Scientific Opportunities. Research Grants. Research Funding Opportunities. Cancer Grand Challenges.
Research Program Contacts. Funding Strategy. Grants Policies and Process. Introduction to Grants Process. NCI Grant Policies. Legal Requirements. Step 3: Peer Review and Funding Outcomes. Manage Your Award. Grants Management Contacts. Flat warts Open pop-up dialog box Close. Flat warts Flat warts are smaller and smoother than other warts. Female genital warts Open pop-up dialog box Close. Female genital warts Genital warts are a common sexually transmitted infection.
Male genital warts Open pop-up dialog box Close. Male genital warts Genital warts are a common sexually transmitted infection. Request an Appointment at Mayo Clinic. More Information HPV vaccine. Share on: Facebook Twitter. Show references Jameson JL, et al. Human papillomavirus infections. In: Harrison's Principles of Internal Medicine.
New York, N. Accessed Feb. Bennett JE, et al. Philadelphia, Pa. American Academy of Dermatology. Human papillomavirus HPV vaccination.
Rochester, Minn. HPV vaccine. Centers for Disease Control and Prevention. Accessed Oct. Anogenital warts. Human papillomavirus HPV and cervical cancer. World Health Organization. Palefsky JM. Corresponding author. Received Apr 6; Accepted Jun 9. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material.
If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Subject terms: Biological techniques, Biotechnology, Microbiology. Introduction Human papillomavirus HPV infection is a major causative agent of cervical cancer in women 1. Open in a separate window. Figure 1. Figure 2. Figure 3. Figure 4. Figure 5. Figure 6. Analytical specificity analysis The specificity of the assay was evaluated by testing DNAs from other HPV types HPV6, 11, 26, 44, 54, 55, 61, 67 , and other common vaginal pathogens chlamydia trachomatis, mycoplasma hominis, trichomonas vaginalis, treponema pallidum, streptococcus pyogenes, candida albicans, herpes simplex virus.
Supplementary Information Supplementary Information. Author contributions G. Footnotes Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information Liang Xue, Email: moc. Supplementary Information The online version contains supplementary material available at References 1. The causal relation between human papillomavirus and cervical cancer. Ginsburg O, et al. Ma B, et al. A simple and efficient method for potential point-of-care diagnosis of human papillomavirus genotypes: Combination of isothermal recombinase polymerase amplification with lateral flow dipstick and reverse dot blot.
Urquiza M, et al. Two L1-peptides are excellent tools for serological detection of HPV-associated cervical carcinoma lesions. Hildesheim A, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women.
Manos M. The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells. Qu W, et al. Lee HP, et al.
Satoh T, et al. Chen JS, et al. Barrangou R, et al. Fozouni P, et al. Xiong D, et al. PLoS Biol.
0コメント